Anil Babu Payedimarri
Biographic Data
| ID | 7851585 |
|---|---|
| NAME | Anil Babu Payedimarri |
| GIVEN NAMES | Anil Babu |
| FAMILY NAME | Payedimarri |
| SIGNATURE | PAYEDIMARRI A B |
| AFFILIATIONS | Università degli Studi del Piemonte Orientale “Amedeo Avogadro” |
| ORCID | 0000-0003-4298-1305 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Assessing patterns of authorship of low- and middle-income countries in global commercial clinical trials in oncology
Poor authorship practices in global health research may be a sign of unequal partnerships. Previous studies have shown that authors from low- and middle-income countries (LMICs) are frequently underrepresented in publications from global research collaborations between LMICs and high-income countries (HICs). To the best of our knowledge, the patterns of authorship from LMICs in international industry-sponsored clinical research on breast, lung an…
Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe
INTRODUCTION: Access to essential medicines is a critical element of health systems and an important measure of their performance. Migrants may face barriers in accessing healthcare, including essential medicines, throughout the migration cycle, which includes the stages of departure from home or residence countries, transit through non-European or European countries, reception and settlement in a country in Europe and deportation. We aim to prov…
Development of a Model Care Pathway for Myasthenia Gravis
Myasthenia Gravis (MG) is a chronic, life-lasting condition that requires high coordination among different professionals and disciplines. The diagnosis of MG is often delayed and sometimes misdiagnosed. The goal of the care pathway (CP) is to add value to healthcare reducing unnecessary variations. The quality of the care received by patients affected with MG could benefit from the use of CP. We conducted a study aimed to define an inclusive, co…
No prominent works on this page.
Development of a Model Care Pathway for Myasthenia Gravis
Myasthenia Gravis (MG) is a chronic, life-lasting condition that requires high coordination among different professionals and disciplines. The diagnosis of MG is often delayed and sometimes misdiagnosed. The goal of the care pathway (CP) is to add value to healthcare reducing unnecessary variations. The quality of the care received by patients affected with MG could benefit from the use of CP. We conducted a study aimed to define an inclusive, co…
Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe
INTRODUCTION: Access to essential medicines is a critical element of health systems and an important measure of their performance. Migrants may face barriers in accessing healthcare, including essential medicines, throughout the migration cycle, which includes the stages of departure from home or residence countries, transit through non-European or European countries, reception and settlement in a country in Europe and deportation. We aim to prov…
Assessing patterns of authorship of low- and middle-income countries in global commercial clinical trials in oncology
Poor authorship practices in global health research may be a sign of unequal partnerships. Previous studies have shown that authors from low- and middle-income countries (LMICs) are frequently underrepresented in publications from global research collaborations between LMICs and high-income countries (HICs). To the best of our knowledge, the patterns of authorship from LMICs in international industry-sponsored clinical research on breast, lung an…
MEDLINE (3 works) · Business (2 works) · Health care (2 works) · Medicine (2 works) · Political science (2 works) · Alternative medicine (1 work) · Clinical research (1 work) · Clinical trial (1 work) · Colorectal cancer (1 work) · Commission (1 work)